IBD Research at the Zane Cohen Centre

Print

Information on research and clinical trials in Inflammatory Bowel Disease

Current Studies

Crohn's Disease & Ulcerative Colitis

Ulcerative colitis

Ulcerative colitis study involving an investigational subcutaneous medication (AMG 181). Double-blind, placebo controlled study.
Objective is to study 4 doses of AMG 181 compared to placebo. There is an option to enter an open-label study following this one.


Crohn's Disease

  • Crohn's disease study involving an investigational intravenous and subcutaneous medication (MEDI2070 - IL-23). Double-blind, placebo controlled study.
    Objective is to study one dose of MEDI2070 compared to placebo. There is an option to enter an open-label study following this one.

  • Crohn's disease study involving an investigational subcutaneous medication (AMG 181). Double-blind, placebo controlled study.
    Objective is to study 4 doses of AMG 181 compared to placebo. There is an option to enter an open-label study following this one.


Hepatobiliary Bowel Study

WE INVITE YOU TO PARTNER WITH US TODAY
Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Joseph and Wolf Lebovic Health Complex. Copyright © 1997 - 2013.
All Rights Reserved. A patient care, teaching and research centre affiliated with University of Toronto.
Powered by Joomla 1.7 Templates